After mechanistic validation of our findings, quantifying expression levels of HS3ST2 and CD40LG from leprosy lesions could be useful to assess immune responsiveness against M. leprae, help patient stratification and/or provide a basis for host-based adjuvant treatment for leprosy lesions. The gene discussed is CD40LG; the disease is leprosy.